Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Sonova Holding AG    SOON   CH0012549785

SONOVA HOLDING AG

(SOON)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sonova raises guidance reflecting faster business recovery and expects to return to growth in 2H 2020/21

share with twitter share with LinkedIn share with facebook
09/28/2020 | 02:05am EDT

Sonova raises guidance reflecting faster business recovery and
expects to return to growth in 2H 2020/21

Stäfa (Switzerland), September 28, 2020 - Sonova Holding AG, a leading provider of hearing solutions, today raises its guidance for the first half of FY 2020/21. Following the business update on July 6, 2020 Sonova's business activities have picked up faster than anticipated, supported by the ongoing recovery of the global hearing care market from the COVID-19 pandemic impacts. Moreover, the Group's internal growth and productivity initiatives are increasingly bearing fruit. As a result, Sonova now expects sales for the first half of FY 2020/21 to reach around 79% of the prior year level at constant exchange rates and to achieve an adjusted EBITA margin in Swiss francs of approximately 15% for the same period. For the second half of the financial year, the Group expects to return to growth, achieving a revenue increase of 4%-8% and a rise in the adjusted EBITA in the range of 20%-30% compared with the prior year period, both at constant exchange rates.

Arnd Kaldowski, CEO of Sonova, says: "During the past months, our business has performed above expectations, driven by a strong product portfolio, the successful execution on our growth and productivity initiatives and supported by improved market conditions. This was only possible thanks to the dedication of our employees and swift action throughout our company to address the current market challenges. Supported by the successful launch of our new Phonak Paradise platform, we expect to return to positive growth in the second half of our business year. Coupled with the acceleration of our efforts to optimize our organizational structure, this is expected to drive a strong growth in profitability for the remainder of the financial year."

The market recovery continued to progress faster than anticipated, positively impacting Sonova's business activities. While the overall hearing instruments market remained modestly below prior year levels in recent weeks, some major markets have returned to growth. The cochlear implants market improved as well, albeit at a considerably slower pace than the hearing instruments market as many hospitals continue to operate at reduced surgical volumes. For the Sonova Group, the APAC region continued to lead the recovery in the second quarter of FY 2020/21 with sales growth at constant exchange rates estimated at around 4%, followed by the regions EMEA and Americas (excl. US) at approximately prior year levels. In the United States, sales were close to 10% lower than the prior year level.

As a result and reflecting the year-to-date performance, Sonova therefore raises its guidance for the first half of the financial year 2020/21, expecting Group sales to reach around 79% (previous guidance: 65-75%) of prior year levels and the adjusted EBITA to decline by approximately 30%, both at constant exchange rates. This implies an adjusted EBITA margin in Swiss francs of around 15% (previous guidance: in the single digits at constant exchange rates).

For the second half of the financial year 2020/21, the Group expects revenue growth of 4%-8% and an increase of the adjusted EBITA in the range of 20%-30% compared with the prior year period, both at constant exchange rates. The outlook assumes a continued gradual market recovery absent any significant re-tightening of lockdown restrictions. While the speed of the recovery so far has been encouraging, the current rise in infection rates in several markets illustrates the continued risk to the expected upward trend.

For FY 2020/21, this implies that sales are expected to reach 92%-94% of prior year levels and an adjusted EBITA at around prior year level, both at constant exchange rates. As a consequence of the strengthening of the Swiss franc and reflecting current exchange rates, Sonova anticipates reported sales growth in Swiss francs to be reduced by around 4 percentage points and the adjusted EBITA growth in Swiss francs to be negatively affected by around 10 percentage points in FY 2020/21.

Investor and analyst conference call

Sonova will host a conference call for investors and analysts, today, September 28, 2020, at 08.30 AM CEST to discuss today's announcement. Participants are kindly requested to dial in 10-15 minutes prior to the start of the call.

The conference call can be accessed at:

+41 (0) 58 310 50 00 (Europa)

+44 (0) 207 107 06 13 (UK)

+1 (1) 631 570 56 13 (USA)

- End -




Provider
Channel
Contact
Tensid EQS Ltd., Switzerland
www.tensid.ch


newsbox.ch
www.newsbox.ch


Provider/Channel related enquiries
marco@tensid.ch
+41 41 763 00 50

share with twitter share with LinkedIn share with facebook
All news about SONOVA HOLDING AG
10/06GLOBAL MARKETS LIVE : Tech giants in the hot seat
10/06SONOVA INVESTOR AND ANALYST DAY 2020 : Successfully navigating in a challenging ..
TE
09/28Bank stocks bounce off record low, helping Europe recover some lost ground
RE
09/28Bank stocks bounce off record low, helping Europe recover some lost ground
RE
09/28Sonova raises guidance reflecting faster business recovery and expects to ret..
TE
08/19Sonova introduces Paradise technology platform, a new paradigm in hearing aid..
TE
07/15SONOVA : sales could return to pre-crisis levels by mid-2021, CEO tells website
RE
07/08Swiss June unemployment rate falls, jobless numbers up 55% from 2019
RE
07/06China rally triggers gains in European cyclical stocks
RE
07/06SONOVA : sees partial recovery in H1, announces job cuts
RE
More news
Financials
Sales 2021 2 578 M 2 811 M 2 811 M
Net income 2021 403 M 439 M 439 M
Net Debt 2021 275 M 300 M 300 M
P/E ratio 2021 34,4x
Yield 2021 1,04%
Capitalization 13 578 M 14 821 M 14 804 M
EV / Sales 2021 5,37x
EV / Sales 2022 4,49x
Nbr of Employees 15 184
Free-Float 81,1%
Chart SONOVA HOLDING AG
Duration : Period :
Sonova Holding AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SONOVA HOLDING AG
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 21
Average target price 222,46 CHF
Last Close Price 217,50 CHF
Spread / Highest target 39,3%
Spread / Average Target 2,28%
Spread / Lowest Target -42,9%
EPS Revisions
Managers
NameTitle
Arnd Kaldowski Chief Executive Officer
Robert F. Spoerry Non-Executive Chairman-Supervisory Board
Ludger Althoff Group Vice President-Operations
Hartwig Grevener Chief Financial Officer
Andi Vonlanthen Group Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
SONOVA HOLDING AG-1.81%14 821
ABBOTT LABORATORIES21.01%185 906
MEDTRONIC PLC-11.35%136 283
STRYKER CORPORATION-3.78%75 876
BECTON, DICKINSON AND COMPANY-15.02%67 386
HOYA CORPORATION12.92%42 297